Poster Presentations 2022

All the posters and presentations given in the Poster Hall at AMMF’s Virtual European
can be seen here. Please note: This area is intended for HCPs only.

1) Roseanna C Wheatley, University of Manchester and The Christie NHS Foundation Trust, Manchester

EMBRACER study: Evaluation of the microbiome in patients receiving systemic anti-cancer treatment for biliary tract cancer.

To view the poster and presentation, click here.

2) Raffaella Casolino, University of Glasgow

Audit of the centralized oncology clinic for biliary tract cancers in the West of Scotland.

To view the poster, click here

3) Raffaella Casolino, University of Glasgow and University of Verona

Bridging the equity gap in patient education: the biliary cancer Babel project.

To view the poster, click here

4) Ben Johnson, Medscape Oncology, Amsterdam

Integration of molecular guided therapy for the treatment of advanced cholangiocarcinoma: continuing-online education improves competence and confidence of physicians.

To view the poster and presentation, click here.

5) Margherita Rimini, Vita-Salute San Raffaele University, Milan

Genomic analysis of cholangiocarcinoma identifies distinct IDH-mutated clusters.

To view the poster and presentation, click here.

6) Margherita Rimini, Vita-Salute San Raffaele University, Milan

IDH1 in intrahepatic cholangiocarcinoma: a comparative genomic analysis and clinical impact.

To view the poster and presentation, click here.

7) Margherita Rimini, Vita-Salute San Raffaele University, Milan

IDH1 in intrahepatic cholangiocarcinoma: a comparative genomic analysis and clinical impact.

To view the poster and presentation, click here.

8) Teresa Perra, University of Sassari

Intraoperative assessment of tissue oxygenation for prediction of bile leakage in liver resection with hepaticojejunostomy for cholangiocarcinoma.

To view the poster and presentation, click here.

9) Angela Lamarca, The Christie NHS Foundation Trust, Manchester

Natural history of patients with advanced cholangiocarcinoma (CCA) and FGFR2 gene fusions/rearrangements.

To view the poster and presentation, click here.

10) Angela Lamarca, The Christie NHS Foundation Trust, Manchester

Broadening the therapeutic horizon of cholangiocarcinoma through molecular-targeted treatments/precision medicine.

To view the poster and presentation, click here.

11) Salvador Escorza Calzada, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City

Intrahepatic cholangiocarcinoma associated with hypercalcemia secondary to 1,25 dihydroxyvitamin D in a young adult.

To view the poster and presentation, click here.

12) Francesco Amato, University of Glasgow

Liquid biopsy in biliary tract cancer patients undergoing first line combination chemotherapy.

To view the poster and presentation, click here.

13) Megan Illingworth, Foundation for Liver Research and King’s College, London

Transcriptomic profiling identifies ribosomal proteins as novel genes of interest in primary sclerosing cholangitis associated cholangiocarcinoma.

To view the poster and presentation, click here.

14) Marco Silvestri, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan

Identification of distinct biological subclasses of intrahepatic and extrahepatic cholangiocarcinoma by comprehensive transcriptomic analysis.

To view the poster, click here.

15) Juan Valle, University of Manchester and the Christie NHS Foundation Trust

A Phase 3 randomised, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients with advanced biliary tract cancer (BTC): TOPAZ-1.

To view the poster and presentation, click here